
Cows that SAB Biotherapeutics uses to produce antibodies were modified with a human gene and cloned.
Submitted photoA Sioux Falls company — with its team of scientists and a herd of genetically engineered cows — is working feverishly to develop and produce an effective treatment for people infected with the coronavirus.
SAb Biotherapeutics has emerged as a major player in the effort to generate a viable antidote to the fast-moving virus that is sweeping across the world and the United States, so far sickening more than 140,000 and killing several thousand.
Eddie Sullivan, CEO of SAb, said the company is working on producing a polyclonal antibody therapeutic to coronavirus that it expects will be ready for the pre-clinical and clinical-trial evaluations by the end of the summer, paving the way for a potential treatment shortly thereafter, depending on the pace of regulatory approval.
Click on the link for the rest.